Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Mizuho reaffirmed an Outperform rating and a $125 price objective on Medtronic, reflecting confidence in the company’s cardiac ablation franchise and several recent product and commercial advances. The bank points to pulsed field ablation adoption, growth in electrophysiology resources, and new offerings such as renal denervation, Altaviva and the …
Mizuho raised its price target for DTE Energy to $155 from $144 while maintaining an Outperform rating, pointing to progress in the company’s roughly 3 gigawatt near-term data center pipeline and recent regulatory and operational developments. The new target implies upside from DTE’s current trading level of $144.69. Management highlighted support …
RBC Capital has raised its price objective on RB Global Inc to $146 from $137 while keeping an Outperform rating after the company posted fourth-quarter results that beat consensus and issued a 2026 gross transaction value outlook ahead of RBC's estimates. The firm described RB Global's adjusted EBITDA guidance as at least meeting expectations and …
Needham has lowered its price target on Gemini Space Station (GEMI) to $10.00 from $23.00 but left its Buy rating intact, citing a deteriorating crypto revenue outlook and company cost reductions. The firm projects a sharp drop in crypto activity in early 2026 and expects adjusted EBITDA to improve in the back half of the year after expense cuts. T…
RBC Capital reduced its 12-month price target on Loar Holdings Inc (NYSE: LOAR) to $90 from $92 while retaining an Outperform rating. The change follows an internal estimate update ahead of Loar's fourth-quarter fiscal 2025 earnings release and incorporates the company’s recent acquisitions of LMB Fans & Motors and Harper Engineering. RBC highlight…
RBC Capital cut its price target on Leidos Holdings to $215 from $230 while retaining an Outperform rating, citing headwinds from slower VBA activity despite progress in profitability and a strategic shift toward defense technology and higher capital spending. Leidos posted mixed fourth-quarter 2025 results with an EPS beat but a slight revenue sho…
Pakistan’s prime minister plans to use a Washington meeting of President Donald Trump’s Board of Peace to obtain firm assurances from the United States that any deployment by Islamabad to the proposed International Stabilization Force (ISF) in Gaza would be strictly a peacekeeping mission, government sources say. Pakistani officials have made clear…
Shares of cloud data analytics provider Snowflake (SNOW) have tumbled more than 30% since its fiscal third-quarter report. Citi analyst Tyler Radke maintained a Buy rating while trimming his price target to $270 from $300, contending that the market reaction was excessive given evidence of durable AI-driven consumption and constructive channel chec…
H.C. Wainwright increased its 12-month price target for Genmab A/S to $40 from $39 and retained a Buy rating. The upgrade follows a revised discounted cash flow valuation that highlights DARZALEX royalties and the company�s pipeline. Genmab posted $3.7 billion in revenue for 2025 with $2.44 billion in DARZALEX royalties and reported net earnings of…
Piper Sandler increased its price target on Amgen Inc. to $432 from $381 and kept an Overweight rating after discussions with company management and updated modeling that incorporated Amgen's recent revenue growth and higher sales forecasts for key products. The move follows robust fourth-quarter results and a range of analyst reactions across the …
RBC Capital increased its price target for Compass Pathways (NASDAQ:CMPS) while sustaining an Outperform rating after the company presented Phase III and longer-term follow-up data showing no red flags. The data underscore COMP360's potential to deliver durable benefit for treatment-resistant depression after one or two doses, supporting a commerci…
Piper Sandler raised its price target on Cogent Biosciences to $52 from $39 and kept an Overweight rating, citing the company's transition toward regulatory approvals and commercial readiness following late-2025 data. Key upcoming milestones include multiple New Drug Application submissions and potential approvals that could lead to launches in the…
Piper Sandler raised its price target on Tactile Systems Technology (TCMD) to $42 from $35 while keeping an Overweight rating, following fourth-quarter revenue that beat expectations and company guidance for fiscal 2026 of $357 million to $365 million. The firm noted continued strength in the lymphedema business, cited recent acquisition activity, …
H.C. Wainwright reduced its price objective on Hive Digital Technologies to $7 from $10 while retaining a Buy rating. The brokerage cited disappointing fiscal third-quarter results ended in December even as Hive reported strong revenue growth and expansion of both GPU cloud and bitcoin mining operations. The firm noted a low probability that the co…
Nektar Therapeutics just cleared a major perception hurdle: clinical maintenance data in atopic dermatitis (AD) tied to rezpegaldesleukin (rezpeg) have driven investor enthusiasm and put the shares into a breakout. Fundamentals remain early-stage — revenues are modest, EPS negative and free cash flow is negative — but the clinical differentiation, …
Airbnb announced a $750 payment for first-time entire-home hosts who complete their initial guest stay by July 31, aiming to grow supply in 16 North American cities preparing for the mid-2026 FIFA World Cup. The move comes as ticket demand and short-term rental pricing climb, and as the tournament may help reverse a recent dip in U.S. inbound trave…
Freedom Capital Markets upgraded Waystar Holding (NASDAQ: WAY) from Hold to Buy following a fourth-quarter performance that topped expectations and an initial fiscal 2026 outlook that beat on EBITDA. The firm lowered its price target to $33 from $40 to account for the balance sheet impact of the Iodine acquisition and a reduced perpetuity growth ra…
Piper Sandler reaffirmed an Overweight rating and an $87.00 price target on Coca-Cola (KO), following remarks by incoming CEO Henrique Braun highlighting digital capabilities and a strategy of steady momentum combined with adaptation to changing markets. The company, valued at $342 billion, continues a long-running dividend increase record and rece…
Piper Sandler reduced its 12-month price target for Merit Medical Systems (MMSI) to $106 from $113 while retaining an Overweight recommendation. The stock is trading well below the new target and close to its 52-week low as investors await an upcoming earnings report and consider recent coverage and leadership changes.
Piper Sandler reduced its price objective for General Mills to $53 from $60 while keeping an Overweight rating, citing increased costs to meet consumer value expectations and an unfavorable shift toward promoted purchases. The firm trimmed fiscal 2026 and 2027 EPS estimates and pointed to product-mix deterioration and slower organic revenue recover…
Piper Sandler reaffirmed an Overweight rating and a $265.00 price target on Palo Alto Networks (NASDAQ: PANW), implying roughly 62% upside from the current share price of $163.50. The firm pointed to a modest second-quarter beat, steady guidance and continued revenue momentum, while management highlighted demand for newer products and recent acquis…
Moody’s issued a full-year adjusted earnings-per-share outlook that slightly exceeds analyst consensus, driven by higher demand for credit ratings amid increased bond issuance from major technology companies. The ratings unit posted solid fourth-quarter revenue growth, and the firm beat quarterly profit expectations, though its stock has endured de…
Cognizant (CTSH) is a beaten-down leader in IT services that is oversold technically and cheap on cash-flow metrics. The business still throws off roughly $2.6B in free cash flow and trades at ~14x earnings and ~12x free cash flow. With AI/cloud-led outsourcing demand and industry-specific momentum in insurance and healthcare, this is a tactical bu…
As Ramadan began in Gaza, many Palestinians marked the month amid the rubble of destroyed mosques or in improvised prayer spaces made from tarpaulins and wood. Families displaced by the conflict are using former mosque courtyards for shelter and daily life, while local officials report dozens of rebuilt prayer areas created from recycled materials …
Guggenheim increased its price target for PepGen Inc. (PEPG) from $6 to $7 while retaining a Buy rating. The firm points to upcoming FREEDOM2 5 mg/kg MAD cohort data in March, which it sees as a catalyst for meaningful upside under several efficacy and safety scenarios. PepGen also appointed Joseph Vittiglio as Chief Business and Legal Officer.
